REGN-9533
- Generic Name
- REGN-9533
Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 56
- Registration Number
- NCT06665828
- Locations
- 🇧🇪
SGS Belgium NV_Edegem, Edegem, Antwerp, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath